TCIM
DMTX

TIAA CREF Investment Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

TIAA CREF Investment Management’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-49,784
Closed -$87K – 3276
2017
Q1 		$87K Buy
49,784
+2,730
+6% +$7.24K ﹤0.01% 3052
2016
Q4 		$205K Buy
47,054
+6,486
+16% +$34.5K ﹤0.01% 3040
2016
Q3 		$324 Sell
40,568
-1,085
-3% -$7.84K ﹤0.01% 2983
2016
Q2 		$250K Buy
41,653
+34,517
+484% +$263K ﹤0.01% 3062
2016
Q1 		$56K Buy
+7,136
New +$56.2K ﹤0.01% 3062

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

TIAA CREF Investment Management's DMTX Position: Q2 2017 in Review

TIAA CREF Investment Management sold out of Dimension Therapeutics, Inc (DMTX) in Q2 2017, closing a stake of 49,784 shares — an estimated $87K sold.

TIAA CREF Investment Management first reported a position in DMTX in Q1 2016 and held it in 5 quarters. The position peaked at $250K in Q2 2016. 35 funds tracked by Wall St. Rank hold DMTX as of Q2 2017.

  • TIAA CREF Investment Management reported no remaining Dimension Therapeutics, Inc position as of Q2 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 49,784 Dimension Therapeutics, Inc shares in Q2 2017, an estimated $87K.
  • TIAA CREF Investment Management first reported a position in Dimension Therapeutics, Inc in Q1 2016 and held it in 5 quarters.
  • TIAA CREF Investment Management's Dimension Therapeutics, Inc position peaked at $250K in Q2 2016.
  • 35 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q2 2017.

Based on TIAA CREF Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.